Utrecht University

Artmarket.com: CIHA Lyon 2024 - France. Artprice is an active sponsor of the International Congress of Art History (CIHA) which this year will be attended by a thousand researchers from over 70 countries

Retrieved on: 
Dienstag, Mai 7, 2024
Grenoble Alpes University, Le Puy-en-Velay, Partnership, Library, Sheela Gowda, Human, Speech, History, Le Corbusier, CIHA, INHA, Digital technology, Congress, Museum, Scientific method, Samuel Henry Kress, World Heritage Site, Ferdinand Cheval, Committee, Congress Center, Utrecht University, EHESS, Clothing, Firminy, University of Aberdeen, Materiality, ARC, Publication, Heart, Collection, CFHA, Dixit, Foreign Affairs, Abode of Chaos, Trade, Perception, Artifact, Circle, Contemporary Art Museum, University, Michelin, Ministry, UNESCO, Painting, Getty Foundation, Tourism

For France, which is hosting the 2024 Olympic Games in Paris, the CIHA will rank among the country's major events of the year.

Key Points: 
  • For France, which is hosting the 2024 Olympic Games in Paris, the CIHA will rank among the country's major events of the year.
  • With participants from over 70 countries and more than 1000 speakers, this year's CIHA will be a superb intellectual complement to the 2024 Olympic Games in Paris.
  • And, considering Artprice's contribution to Art History by enhancing art market transparency, their support of this Congress is a great honor and makes perfect sense.
  • The CIHA Lyon 2024 Congress is open to anyone interested in art, Art History and cultural heritage.

Artmarket.com: CIHA Lyon 2024 - France. Artprice is an active sponsor of the International Congress of Art History (CIHA) which this year will be attended by a thousand researchers from over 70 countries

Retrieved on: 
Dienstag, Mai 7, 2024
Grenoble Alpes University, Le Puy-en-Velay, Partnership, Library, Sheela Gowda, Human, Speech, History, Le Corbusier, CIHA, INHA, Digital technology, Congress, Museum, Scientific method, Samuel Henry Kress, World Heritage Site, Ferdinand Cheval, Committee, Congress Center, Utrecht University, EHESS, Clothing, Firminy, University of Aberdeen, Materiality, ARC, Publication, Heart, Collection, CFHA, Dixit, Foreign Affairs, Abode of Chaos, Trade, Perception, Artifact, Circle, Contemporary Art Museum, University, Michelin, Ministry, UNESCO, Painting, Getty Foundation, Tourism

For France, which is hosting the 2024 Olympic Games in Paris, the CIHA will rank among the country's major events of the year.

Key Points: 
  • For France, which is hosting the 2024 Olympic Games in Paris, the CIHA will rank among the country's major events of the year.
  • With participants from over 70 countries and more than 1000 speakers, this year's CIHA will be a superb intellectual complement to the 2024 Olympic Games in Paris.
  • And, considering Artprice's contribution to Art History by enhancing art market transparency, their support of this Congress is a great honor and makes perfect sense.
  • The CIHA Lyon 2024 Congress is open to anyone interested in art, Art History and cultural heritage.

Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management Team

Retrieved on: 
Dienstag, April 9, 2024
College, Neurology, Neoplasm, Brain, M.B.A, Utrecht University, Oncology, Neuro, Central nervous system, Novartis, CNS, GBM, Biostatistics, Committee, Biology, Breast, University, Neurosurgery, PSTV, Cancer, Plus, Science park, Doctor of Philosophy, Glioblastoma, Therapy, Texas A&M University, Drug development, Halozyme, Plus Therapeutics, Pharmaceutical industry

AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announced that Andrew Brenner, M.D., Ph.D. (Professor-Research, Departments of Medicine, Neurology, and Neurosurgery & S & B Kolitz/CTRC-Zachry Endowed Chair Neuro-Oncology Research, Mays Cancer Center at UT Health San Antonio) has formally joined the Company in a part-time capacity. Dr. Brenner will provide substantial input on the Company’s central nervous system cancer development programs while continuing to maintain his academic practice and laboratory. In addition, Barbara Blouw, Ph.D. joins the Company as Vice President, Clinical Affairs.

Key Points: 
  • Dr. Brenner will provide substantial input on the Company’s central nervous system cancer development programs while continuing to maintain his academic practice and laboratory.
  • In addition, Barbara Blouw, Ph.D. joins the Company as Vice President, Clinical Affairs.
  • Dr. Brenner’s academic work focuses on both clinical cancer management and the development of novel therapies to treat breast and central nervous system tumors.
  • Dr. Brenner has received numerous grants and investigational new drug approvals based on his translational research.

SIAM Announces Class of 2024 Fellows

Retrieved on: 
Donnerstag, März 28, 2024
CNRS, Editorial, Mathematics, Sorbonne University, Climate change, Algorithm, Masaryk University, Utrecht University, Data science, State university system, Cornell University, Systems theory, University of Utah, City University, University of Massachusetts, Research, University of British Columbia, Platelet, University, Software, IBM, University of Cambridge, University of Exeter, Statistics, Industrial, Rutgers University, University of Zurich, University of Waterloo, Stanford University, Virginia Tech, Probability, Lehigh University, Engineering, Lawrence Berkeley National Laboratory, Information technology

Philadelphia, PA, March 28, 2024 (GLOBE NEWSWIRE) -- Society for Industrial and Applied Mathematics (SIAM) is pleased to announce the 2024 Class of SIAM Fellows.

Key Points: 
  • Philadelphia, PA, March 28, 2024 (GLOBE NEWSWIRE) -- Society for Industrial and Applied Mathematics (SIAM) is pleased to announce the 2024 Class of SIAM Fellows.
  • Through their various contributions, SIAM Fellows form a crucial group of individuals helping to advance the fields of applied mathematics, computational science, and data science.
  • Hans De Sterck, University of Waterloo, is being recognized for contributions to scientific computing methods including multilevel and nonlinear solvers, and for exemplary scientific leadership and service to SIAM.
  • Fred S. Roberts, Rutgers University, is being recognized for distinguished research in discrete mathematics, leadership of major research centers, and service to SIAM.

Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO

Retrieved on: 
Montag, März 11, 2024
Software, Research, Hardware, Pharmaceutical, Oncology, Technology, Medical Devices, Infectious Diseases, Genetics, Health Technology, Science, Biotechnology, Health, QC, GPU, Utrecht University, Pharmacy, IRT, Drug discovery, Radboud University Nijmegen, Cell biology, Biomarker, Molecular genetics, Bruker, University, Ultra, University of Michigan, Proteomics, Peptide, Infection, Pulse, Neoplasm, Glycomics, Lunenfeld-Tanenbaum Research Institute, TIMS, Multimedia, Medical director, BRKR, Pathology, Medical device

At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows.

Key Points: 
  • At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows.
  • The rapid advances in deep, at-scale proteomics, glycomics and peptidomics research solutions complement other performance-leading life-science tools for the post-genomic era by Bruker.
  • Bruker enhances its timsTOF HT and timsTOF Ultra systems with the new software Novor v2.0 for de novo immunopeptidomic profiling.
  • Our software suite supports the analysis of PASEF data, and we are delighted that Bruker now offers it with timsTOF instruments.

Professor René Bernards to Present New Pre-Clinical Data on LIXTE’s LB-100 at Joint Conference of European and American Associations for Cancer Research

Retrieved on: 
Dienstag, Februar 27, 2024
Head, Doctor of Philosophy, Aggression, Utrecht University, PP2A, Patient, Netherlands Cancer Institute, Pharmaceutical industry

PASADENA, CA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”), a clinical stage biotechnology company developing a novel class of cancer therapy called PP2A inhibitors, today announced that René Bernards, PhD, professor of molecular carcinogenesis at Utrecht University in Amsterdam and head of molecular carcinogenesis at the Netherlands Cancer Institute, will present new pre-clinical data on LIXTE’s lead compound, LB-100, at the Joint Conference of European and American Associations for Cancer Research this week in Dublin, Ireland. Dr. Bernards is also a member of LIXTE’s Board of Directors.

Key Points: 
  • Dr. Bernards is also a member of LIXTE’s Board of Directors.
  • In his presentation, “Unexpected, but Highly Synergistic Combinations for Cancer Therapy,” Dr. Bernards will present data on how stress imposed onto colon cancer cells by LB-100 drives cancer cells to evolve to less cancerous behavior.
  • “The findings underscore the unique and what we believe to be exciting features and mechanism of action of LIXTE’s PP2A inhibitor, LB-100,” said Dr. James Miser, LIXTE’s Chief Medical Officer.
  • “While conventional cancer drugs aim to inhibit oncogenic signaling, which tends to drive cancer cells into more aggressive behavior, LB-100 does exactly the opposite, overloading oncogenic signaling, and thereby forcing cells to downregulate the signals that are characteristic for cancer cells.

Axogen Announces Promotions on Research and Development Team

Retrieved on: 
Donnerstag, Januar 4, 2024
Utrecht University, Quality of life, Neurosurgery, Mercer University, Artivion, Biomedical engineering, Georgetown University, BLA, Virginia Commonwealth University, Mercer, Research, Medical director, Neuroscience, Nerve, Engineering, NDA, Society, Medical education, MedStar Georgetown University Hospital, Program management, University, IDE, Project Management Institute, Hospital, Growth, Patient, Diagnosis, Kohlberg Kravis Roberts, Development, Clinical research, Plastic surgery, Management

ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) --  Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the promotions of three research and development team members.

Key Points: 
  • ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) --  Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the promotions of three research and development team members.
  • The promotions are:
    Mr. DeVinney joined Axogen in April of 2007 as Director of Clinical Research.
  • During his tenure, he has held positions of progressive responsibility in Clinical Research, Research and Development, Product Development, Medical Education, and Medical Affairs.
  • He has a diverse background, including academic research and the development of tissue technologies, medical devices, pharmaceuticals, and biologics.

FertilityIQ Announces First-of-Its-Kind Menopause Education Offering & Record Uptake Amongst Employers and Patients

Retrieved on: 
Mittwoch, November 29, 2023
LGBTQ+, Mental Health, Health, Consumer, Women, Other Health, Woman, Osteoporosis, Brain, Hot, Fertility, Gynaecology, International Menopause Society, Irritability, Endocrinology, Menopause, Psychology, Patient, North American Menopause Society, University, Harvard Medical School, Spouse, Imperial College London, Utrecht University, Quality of life, Education, Nursing

FertilityIQ, the global leader for fertility and family-building digital education, today announced the first-of-its-kind menopause education offering.

Key Points: 
  • FertilityIQ, the global leader for fertility and family-building digital education, today announced the first-of-its-kind menopause education offering.
  • The complete educational offering for women, patients, and employees offers crucial information for those going through perimenopause and the menopause transition.
  • "Great education is critical to helping women through menopause.
  • FertilityIQ's global courses are a valuable resource for patients, spouses, and employers," says Dr. Nick Panay, the current president of the International Menopause Society and past Chair of the British Menopause Society.

Discovery Lithium Adds James Bay Claims and Appoints Directors

Retrieved on: 
Dienstag, September 19, 2023
Lithium, Agreement, HSP, CSE, PI, Share (finance), Policy, Sellers, History, Strategic planning, FRA, Doctor of Philosophy, DCLI, EGBC, Nickel, Master of Science, Corporation, OTC, Acquisition, Simon Fraser University, Jaap, Utrecht University, Growth, Havre-Saint-Pierre, News, Economics, Metal, Security (finance)

Company President & CEO Michael Gheyle states, “Todays announcement reflects our ambition to build a robust portfolio of prospective lithium claims in the province of Quebec.

Key Points: 
  • Company President & CEO Michael Gheyle states, “Todays announcement reflects our ambition to build a robust portfolio of prospective lithium claims in the province of Quebec.
  • We are excited by our opportunity for discovery in Nunavik, and equally thrilled to have an opportunity to explore alongside some of the advanced plays in the James Bay region.
  • A diversified portfolio allows us to manage field crews, logistics, and economics as part of a larger strategic plan for the entire region.
  • We also welcome Jaap and Eric to our board who will help build our governance and policy oversight at this critical juncture of growth.

920 million people could face conflict over the world's rivers by 2050: what our study found in Africa

Retrieved on: 
Sonntag, Juni 25, 2023
Grand Ethiopian Renaissance Dam, Face, Perception, IHE Delft Institute for Water Education, Wageningen University & Research, Research, Goal, Nile, Projection, Literature, US, Climate change, Population, River, Risk, Water, Horn, Utrecht University, Climate, Efficiency, Environment, Population growth, Dam, Canal, Oil, Agriculture, Lake Turkana

Sudan and Egypt consider the US$4.6 billion dam a threat to vital water supplies.

Key Points: 
  • Sudan and Egypt consider the US$4.6 billion dam a threat to vital water supplies.
  • This is just one example of how conflicts can arise between states that share river basins.
  • Although cooperation historically prevails over conflict and large-scale violent international conflicts haven’t happened so far, tensions over water have long existed.
  • If nations improve water use, strengthen cooperation and do more to prevent or mitigate conflict, this number drops to 536 million.
  • Water treaties and strong river basin organisations increase the likelihood of long-term, stable cooperation between states.

Our research

    • It looked at hydroclimatic, governance and socio-economic risk factors.
    • Combining these factors provided an idea of the overall conflict risk per transboundary river basin.
    • A lack of cooperation between countries can lead to a loss of benefits that could arise from joint activities.

Our findings

    • In Africa, this number includes people living in Eritrea, Ethiopia, Rwanda, Uganda, Kenya, Somalia, Burkina Faso, Mauritania and Niger.
    • In the high ambition scenario – which implies improved water use practices and rising institutional resilience – this number decreases to 536 million.
    • Under this scenario, 724 million people would be living in very high to high conflict-risk basins by 2050.

What it means

    • Seven of these dams would be in Ethiopia, and the other four would be in South Sudan.
    • The construction of these dams would be happening alongside rising water shortages, high water dependencies and limited economic resources to deal with water-related risks.
    • In these two basins, multiple issues, such as local conflict, low human development and limited water availability already collide today.
    • For example, when large hydropower dams are built, their operation must not hinder the climate adaptation goals of the wider region.